Joinn Laboratories China Co Ltd
SSE:603127
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
12.46
27.15
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Joinn Laboratories China Co Ltd
Net Income (Common)
Joinn Laboratories China Co Ltd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
J
|
Joinn Laboratories China Co Ltd
SSE:603127
|
Net Income (Common)
ÂĄ136.6m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Net Income (Common)
ÂĄ8.5B
|
CAGR 3-Years
30%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
||
Pharmaron Beijing Co Ltd
SZSE:300759
|
Net Income (Common)
ÂĄ1.9B
|
CAGR 3-Years
15%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
||
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Net Income (Common)
ÂĄ2.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
||
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Net Income (Common)
ÂĄ958.7m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
7%
|
CAGR 10-Years
24%
|
||
W
|
WuXi XDC Cayman Inc
HKEX:2268
|
Net Income (Common)
ÂĄ283.5m
|
CAGR 3-Years
121%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Joinn Laboratories China Co Ltd
Glance View
Joinn Laboratories China Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Beijing, Beijing and currently employs 2,140 full-time employees. The company went IPO on 2017-08-25. Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The firm conducts its businesses both in the domestic market and overseas markets.
See Also
What is Joinn Laboratories China Co Ltd's Net Income (Common)?
Net Income (Common)
136.6m
CNY
Based on the financial report for Jun 30, 2024, Joinn Laboratories China Co Ltd's Net Income (Common) amounts to 136.6m CNY.
What is Joinn Laboratories China Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
2%
Over the last year, the Net Income (Common) growth was -83%. The average annual Net Income (Common) growth rates for Joinn Laboratories China Co Ltd have been -30% over the past three years , 2% over the past five years .